In type 2 diabetes with chronic kidney disease, semaglutide slowed the progression of kidney damage by about 24%
Assessed were the inferior caval vein (which was occluded), right ovarian vein (which appears as blind vessel due to the infrarenal occlusion), and left ovarian vein (which serves as a bypassing pathway) (Vukojevic et al., 2018)
But even today, more than three decades after BPC-157 was first synthesized, a grand total of three human studies have been conducted, and none of them were the kind of large-scale human trial thats typically part of the traditional drug-approval process
This suggests that tDCS strengthens the inhibitory effect of Purkinje neurons upon cerebellar nuclei and that tDCS improves muscle function
Also, as I predicted with my last blog on this topic, it wouldnt be long before FDA put a stop to the peptide compounding pharmacy game